Dr. Kaya de Barbaro is an Associate Professor in the Department of Psychology at the University of Texas at Austin (College of Liberal Arts). She holds a Ph.D. from the University of California San Diego. Her research focuses on bridging computer science and developmental/clinical psychology, particularly maternal mental health and infant social-emotional development. She directs the Daily Activity Lab, which uses mobile/wearable sensors and machine learning to analyze real-world interactions, aiming to develop just-in-time interventions for new mothers. Key research areas include maternal-infant dynamics, physiological synchronization, and the impact of environmental chaos on development. She has pioneered methods for analyzing high-density data, such as Granger causality and machine learning algorithms to detect behaviors like crying and holding. Recent work emphasizes leveraging ecological momentary assessment surveys and 24-hour LENA audio recordings to understand proximal mechanisms of development. Dr. de Barbaro teaches Psychology 333D (Introduction to Developmental Psychology) and has developed curricula for both in-person and online formats. She is actively involved in training students through the Eureka program at UT Austin. Her lab collaborates on tools like chatbots for postpartum mental health and has published extensively on sensor-based methodologies in developmental science.
Kelly Arnold is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan. Her research integrates systems engineering principles with immunology to investigate variability in immune responses across infection, vaccination, and injury, with a focus on computational modeling and clinical translation. Research Focus Systems-level immune response modeling Vaccination and antibody functionality Vaginal microbiome-host interactions Chronic lung disease progression Computational serology and proteomics Recent Work Her 2025 studies examine SARS-CoV-2 vaccination responses in cancer patients and computational frameworks for vaginal probiotics. Earlier works (2024-2007) span COPD progression, lupus fibrosis, HIV susceptibility, and tissue engineering for fertility preservation. Methodologies include proteomic profiling, network modeling, and microfluidic systems.
Tianxi Cai, ScD, holds the John Rock Professorship in Population and Translational Data Sciences at the Harvard T.H. Chan School of Public Health and is a Professor of Biomedical Informatics at Harvard Medical School. She directs the Translational Data Science Center for a Learning Health System (CELEHS). Her work bridges clinical and basic science data to advance personalized medicine and disease understanding. Institution: Harvard University Departments: Biostatistics (T.H. Chan School) and Biomedical Informatics (HMS) Key Roles: Faculty member since 2002, NIH-funded researcher, and leader in EHR data analytics Research focuses on biomarker evaluation, predictive modeling, high-dimensional data analysis, and survival analysis. Collaborates with the I2B2 Center to integrate clinical and genomic data. Active in developing semi-supervised learning methods for noisy EHR data and real-world evidence generation. Funding : Recent grants include NIH projects on rheumatoid arthritis treatment response (R01AR080193, R21AR078339) and semi-supervised EHR denoising (R01LM013614). Co-leads initiatives on chronic disease endpoints using multi-source data (U01FD007929). Labs/Teams : Directs CELEHS and leads the Cai Lab, focusing on translational data science and machine learning applications in healthcare.
Pinar Keskinocak serves as the H. Milton and Carolyn J. Stewart School Chair and Professor in the H. Milton Stewart School of Industrial and Systems Engineering at the Georgia Institute of Technology. She co-founded and directs the Center for Health and Humanitarian Systems, demonstrating leadership in both academic administration and research innovation. Her career includes prior roles as College of Engineering ADVANCE Professor and interim associate dean for faculty development, alongside industry experience at IBM T.J. Watson Research Center. Her educational foundation includes a Ph.D. in Operations Research from Carnegie Mellon University and M.S. and B.S. degrees in Industrial Engineering from Bilkent University. This rigorous training underpins her interdisciplinary approach to complex societal challenges. Dr. Keskinocak's research pioneers operations research applications for societal impact , with dual emphases on health systems and humanitarian logistics . She develops advanced models for infectious disease dynamics (including COVID-19, malaria, and Guinea worm), vaccination strategies, disaster response, and supply chain optimization. Her work uniquely bridges engineering analytics with real-world implementation through partnerships with the CDC, American Red Cross, Carter Center, and Children's Healthcare of Atlanta. Analysis of her 2023-2025 publications reveals intensifying focus on eradication program modeling for polio and Guinea worm, with increasing integration of machine learning for predictive accuracy in vaccine distribution. A pronounced trend addresses health equity through targeted interventions for under-immunized populations in Sub-Saharan Africa, emphasizing resource allocation under constraints and cross-border coordination challenges. Her scientific recognition includes: INFORMS Fellow (2015) NSF CAREER Award (2001) Outstanding Professional Education Award, Georgia Tech (2018) Denning Award for Global Engagement, Georgia Tech (2016) Women in Engineering Excellence Teaching Award (2005) Moving Spirit Award, INFORMS (2005) Dr. Keskinocak has secured extensive project funding through collaborations with federal agencies and NGOs, directing research on pandemic response systems, vaccine logistics, and disaster debris management. While specific advisees aren't publicly cataloged, her leadership in the Center for Health and Humanitarian Systems mentors numerous graduate researchers through interdisciplinary projects. She significantly influences national policy via National Academies committees addressing supply chain resilience and vaccine distribution infrastructure. The Center for Health and Humanitarian Systems operates as a dynamic hub where engineering rigor meets humanitarian action, coordinating multi-institutional teams to develop deployable solutions for global health crises and disaster response systems.
Dr. Naseem Choudhury is a Professor of Psychology and Neuroscience at Ramapo College of New Jersey, affiliated with the School of Social Science and Human Services (SSHS). She holds a Ph.D. in Experimental Psychology from the University of Vermont. Her research focuses on the neural basis of infant information processing, particularly how perceptual abilities influence typical and atypical development, with an emphasis on familial and sociocultural factors. Her work spans auditory processing in infants at risk for developmental language disorders, electrophysiological studies in children with autism, and cross-cultural analyses of artistic perception. She directs the Palestroni Integrated Neuroscience Lab, exploring neural mechanisms underlying cognitive development. Dr. Choudhury has published extensively in journals like Journal of Neuroscience and Developmental Cognitive Neuroscience , with over 50 peer-reviewed articles since 2002. Her studies often involve ERP and EEG methodologies to track developmental milestones and intervention efficacy in high-risk populations. Her research demonstrates that early auditory experiences shape prelinguistic acoustic mapping and that neuroplasticity interventions improve outcomes for language-impaired children. She collaborates internationally on projects linking sensory perception to linguistic outcomes, particularly in Italian and bilingual populations. Dr. Choudhury’s contributions bridge basic neuroscience and clinical applications, emphasizing early screening and preventive strategies for developmental disorders.
Melissa Koenig serves as Professor and Director of Graduate Studies at the University of Minnesota's Institute of Child Development (ICD), where her research examines social and testimonial learning mechanisms in children through investigations of trust, cultural learning, memory, language, and cognitive development. As a first-generation college student, she prioritizes supporting students navigating academic systems through collaborative mentorship. Education PhD (2002), University of Texas at Austin Her research program spans cognitive development, cross-cultural studies, early childhood, language acquisition, theory of mind, and social-emotional development across peer, parent, and romantic contexts. The lab employs interdisciplinary, multi-method approaches with explicit cultural analysis to advance developmental science, particularly examining how children evaluate information sources and integrate testimony into moral frameworks. Analysis of her 2021-2024 publications reveals dominant themes in epistemic trust development, including how children assess informant credibility through moral behavior, group affiliation, and cultural context. Key trajectories show increasing sophistication in distinguishing epistemic versus practical reasoning, cross-cultural variations in trust attribution, and the developmental emergence of resistance to power-based corruption like bribery. Advising & Mentorship Accepts new PhD students for Fall 2026 cohort Requires prospective students to contact prior to December 1 application deadline Public advising statement details mutual expectations and support structures Specializes in guiding students through academic navigation and hidden curriculum challenges She directs the Early Language and Experience Lab, which maintains a collaborative research environment focused on uncovering constraints and supports for children's social learning across diverse contexts, with particular attention to cultural and socioeconomic variables in developmental processes.
Alison Galvani is the Burnett and Stender Families Professor of Epidemiology at Yale School of Public Health and Yale School of Medicine, where she serves as founding director of the Center for Infectious Disease Modeling and Analysis (CIDMA). Her interdisciplinary work bridges epidemiology, evolutionary ecology, and health economics to inform public health policies for diseases including HIV, Ebola, influenza, and COVID-19. Her research focuses on optimizing vaccination strategies and healthcare interventions through mathematical modeling. Recent studies examine SARS-CoV-2 transmission dynamics, RSV vaccine impact, and integration of social determinants into infectious disease models. She has pioneered frameworks for conflict-induced migration analysis and pharmaceutical policy evaluations. Notable scientific awards include the Bellman Prize, Blavatnik Award for Young Scientists, and Guggenheim Fellowship. Her publications span top journals like The Lancet , Nature Communications , and PNAS , with media coverage in major outlets and policy references.
Professor Larry D. Lynd is a prominent researcher at the University of British Columbia's Faculty of Pharmaceutical Sciences, with additional appointments as a Scientist at the Centre for Health Evaluation and Outcome Sciences (CHEOS) at Providence Health Care Research Institute, Director of the Collaboration for Outcomes Research and Evaluation (CORE), Scholar at the Peter Wall Institute of Advanced Studies, and Associate of the UBC School of Population and Public Health. Dr. Lynd completed his PhD in the Department of Health Care and Epidemiology at UBC and a post-doctoral fellowship in health economics at McMaster University. As a pharmacist (BSP) and epidemiologist, he has developed a distinguished career at the intersection of health outcomes research, epidemiology, and health economics, with a particular focus on the application of large administrative health datasets to inform practice and policy. His research spans multiple high-impact areas including rare diseases, multiple sclerosis, respiratory disease, and genomic medicine. Dr. Lynd leads major research initiatives such as the CANadian PROactive Cohort study for People Living with MS, the GenCOUNSEL study evaluating whole genome sequencing for clinical genetic services, and the Early Health Technology Assessment platform for the Nanomedicines Innovation Network. His recent publications demonstrate a strong emphasis on health technology assessment, genomic medicine implementation, multiple sclerosis outcomes research, and addressing unmet needs in clinical genetic services. Dr. Lynd's scientific contributions have been recognized through prestigious awards including the Dr. John McNeil Excellence in Health Research Mentorship Award (2022), Fellowship in the Canadian Academy of Health Sciences (2018), and the UBC Faculty of Pharmaceutical Sciences PharmD Teaching Award (2014-2015). As a mentor, Dr. Lynd has supervised doctoral students including Tamara Mihic (PhD in Pharmaceutical Sciences) and Kennedy Borle (PhD in Interdisciplinary Studies). He has secured substantial research funding, with recent grants totaling over $5 million from organizations including the Canadian Institutes for Health Research, Genome Canada, MS Society of Canada, and Genome British Columbia. Dr. Lynd actively contributes to health policy through leadership roles on committees including as chair of the Health Canada Special Advisory Committee on Non-Prescription Drugs, Special Advisory Committee to the Respiratory and Allergy Therapies Division of Health Canada, BC Ministry of Health Services Expensive Drugs for Rare Diseases Committee, and the BC PharmaNet Data Stewardship Committee.
Gary M. Shaw is the Rosemarie Hess Professor and Professor (Research) at Stanford University , with courtesy appointments in the Department of Epidemiology and Population Health and Department of Obstetrics & Gynecology - Maternal Fetal Medicine . He serves as Co-PI of the March of Dimes Prematurity Research Center at Stanford and PI of the California Center for Finding Causes and Preventives of Birth Defects . His research focuses on the Epidemiology of birth defects Gene-environment interactions in perinatal outcomes Nutritional factors in reproductive health . He has developed machine learning approaches for precision parenteral nutrition and predictive models for preterm birth, while investigating persistent metabolomic signatures following hypertensive pregnancy disorders. Shaw's recent work explores Climate change impacts on reproductive health Maternal-fetal immune interactions Epigenetic mechanisms in perinatal disease with applications of multiomics to neonatal intensive care units. As a member of Bio-X and the Maternal & Child Health Research Institute , he contributes to translational research networks while serving as Associate Editor for Birth Defects Research and American Journal of Medical Genetics . He supervises Med Scholar Project student Richard Liang Doctoral co-advisor for Saskia Comess and Richard Liang Master's advisor for Lenae Joe while leading the Division of Neonatology as Associate Chair for Clinical Research (2012-2025). His laboratory work integrates Metabolomic profiling Proteomic analysis Computational modeling Machine learning for biomedical data to advance neonatal care through precision medicine approaches.
Deqiong Ma is an Assistant Professor in the Department of Genetics at Yale University School of Medicine and Associate Director of the DNA Diagnostic Laboratory. She holds an MD from Tongji Medical University (1991), a PhD from the University of Tasmania (2003), and completed a postdoctoral fellowship at Duke University and a clinical fellowship at Albert Einstein College of Medicine. Her research focuses on genetic and genomic mechanisms underlying autism spectrum disorders, particularly copy number variants (CNVs), structural variation analysis, and clinical diagnostic methodologies. Key research interests include identifying novel genetic risk factors for autism using advanced genomic techniques, such as homozygosity mapping and fine-scale structural variation analysis. Her work bridges clinical genetics and molecular biology, with applications in diagnostic testing and understanding neurodevelopmental disorders. She collaborates extensively on studies involving autism candidate genes (e.g., MBD5, TBL1X) and genomic pathway analysis. Publications emphasize translational research, including diagnostic improvements for pediatric patients and elucidating genetic architecture in autism. She leads efforts in the DNA Diagnostic Lab to integrate genomic data into clinical practice, focusing on regions of homozygosity and uniparental disomy.
Lieselotte Ahnert serves as a Visiting Professor for Developmental Psychology at the Free University of Berlin's Department of Education and Psychology, specifically within the Department of Developmental Science and Applied Developmental Psychology. Her academic journey began at Humboldt University in East Berlin, where she studied psychology during a period of significant political change in the GDR. After completing her doctorate in 1982, she held various research positions including director of the Interdisciplinary Center for Applied Socialization Research (IZAS e.V.) from 1991-1996 and a visiting scientist position at the National Institutes of Health in Washington from 1996-1999. Prior to her current position at FU Berlin (since 2019), she was a Professor of Developmental Psychology at the University of Vienna from 2008-2019. Professor Ahnert's research focuses on early childhood development, attachment theory, and the specific contributions of fathers to child development. Her work examines how children develop within various caregiving contexts, including the transition from home to childcare settings, the effects of socioeconomic disadvantage on attachment security, and the unique role fathers play in children's language development and emotional regulation. She has conducted extensive research on stress responses in infants during childcare transitions and how care providers influence these responses. Her interdisciplinary approach draws from behavioral biology, genetics, neuroscience, pediatrics, and education to understand the complex interplay between genetic and environmental influences in early development. Ahnert's publication record demonstrates significant contributions to understanding father-child relationships, with recent work exploring how fathers' attachment security and education contribute to early child language skills beyond mothers' influence. Her research has also examined the 'terrible twos' phase, investigating how children cope with frustration and tantrums and how parents support them through these developmental challenges. She has published extensively in high-impact journals including Child Development, Developmental Psychobiology, and Attachment and Human Development. Professor Ahnert has received recognition for her expertise, including being commissioned to provide expertise for the Federal Chancellery of Austria in 2021. Her work has practical applications in early childhood education and intervention programs, particularly in understanding how public childcare can compensate for developmental risks in socioeconomically disadvantaged children. In addition to her research, Ahnert has made significant contributions to academic training and supervision. Her book publications, including 'It's the fathers who matter' (2023) and 'How much mother does a child need?' (2020), bridge the gap between academic research and public understanding of child development. Her work continues to influence both academic discourse and practical approaches to early childhood care and education.
Philip Zelazo is the Nancy M. and John E. Lindahl Professor at the University of Minnesota's Institute of Child Development, where he investigates the development and neural bases of executive function. Previously, he held the Canada Research Chair in Developmental Neuroscience at the University of Toronto. His educational background includes: Honors BA from McGill University (1988) PhD with distinction from Yale University (1993) Zelazo's research centers on executive function—the conscious control of thought, action, and emotion—with emphasis on cognitive complexity, consciousness development through thalamo-cortical circuits, and the distinction between "cool" (dorsolateral prefrontal cortex-associated) and "hot" (orbitofrontal cortex-associated) aspects. His methodologies span experimental, cross-cultural, and electrophysiological (EEG/ERP) approaches, integrating theoretical frameworks like the Cognitive Complexity & Control theory and Levels of Consciousness model. Analysis of his 2017-2024 publications reveals consistent focus on executive function development across childhood, mindfulness-based interventions, socioeconomic impacts on cognitive development, and translational applications for education and mental health. His work increasingly addresses real-world implementation through NIH Toolbox measures and school readiness programs. His major recognitions include: Fellow of the American Psychological Association (APA) Fellow of the Association for Psychological Science (APS) Fellow of the American Association for the Advancement of Science (AAAS) Fellow of the Mind and Life Institute Boyd McCandless Young Scientist Award (APA, 1996) Canada’s Top 40 Under 40 Award 2025 Award for Distinguished Contributions to Developmental Psychology (APA) Zelazo actively mentors doctoral students (open to new advisees in fall 2026) and leads significant grant initiatives, including development of the NIH Toolbox Executive Function measures and NIH Infant and Toddler Toolbox "Cognition and Executive Function" assessments. His interventions target EF promotion in high-risk populations, such as preschoolers experiencing homelessness. He directs the Developmental Social Cognitive Neuroscience Lab, which examines neural mechanisms of executive function using EEG/ERP and behavioral paradigms, with recent projects on mindfulness training effects and socioeconomic adversity impacts.
Edwin Romeijn holds the Jill Stewart Archer Family Chair and Professor position in the H. Milton Stewart School of Industrial and Systems Engineering at Georgia Institute of Technology. He served as School Chair from 2015-2024, overseeing the nation's top-ranked industrial engineering program. Previously, he held faculty positions at the University of Michigan, University of Florida, and Erasmus University Rotterdam, and served as Program Director at the National Science Foundation. Education: Ph.D. in Operations Research (1992), Erasmus University Rotterdam M.S. in Econometrics (1988), Erasmus University Rotterdam Romeijn's research centers on optimization theory and applications , with dual focus areas in radiation therapy treatment planning and supply chain management . His radiation therapy work develops algorithms for cancer treatment planning and clinic scheduling, while his supply chain research addresses integrated optimization of production, inventory, and transportation under demand flexibility, resource constraints, perishability, and uncertainty. His methodologies bridge theoretical operations research with real-world healthcare and logistics systems. His publication portfolio demonstrates consistent contributions to optimization methods across diverse application domains, with recent work spanning healthcare systems, renewable energy, sports analytics, and unconventional logistics. The research exhibits strong methodological continuity in stochastic programming, network optimization, and decision-making under uncertainty. Scientific Awards: Fellow of IISE and INFORMS (2017) Richard C. Wilson Faculty Scholar (2012-2013) Multiple best paper awards in industrial engineering conferences Pierskalla Best Paper Award (2003) Young Investigator’s Award at ICCR (2004) Romeijn has advised numerous graduate students and secured significant research funding through NSF and other agencies. His leadership extends to program direction at NSF and chairing Georgia Tech's Industrial and Systems Engineering school. He maintains active collaborations with healthcare institutions and manufacturing enterprises, translating theoretical advances into practical solutions for radiation oncology and supply chain resilience.
Christine Tardif is an Assistant Professor in the Department of Biomedical Engineering and the Department of Neurology and Neurosurgery at McGill University. As head of the McConnell Brain Imaging Centre lab at the Montreal Neurological Institute, she develops advanced MRI techniques for in-vivo brain imaging, focusing on quantitative mapping of myelin and cortical microstructure. Her work spans methodological innovation (e.g., multi-modal biophysical modeling) and translational applications across preclinical (7 Tesla) and clinical (3 and 7 Tesla) systems. Undergraduate: B.Eng. in Computer Engineering, McGill University (2004) Master's: M.Sc. in Bioengineering, Imperial College London (2006) PhD: Biomedical Engineering, McGill University (2011) Her research explores myelin dynamics in health and disease, emphasizing its role in neural conduction, brain plasticity, and cognitive functions. The lab investigates dysmyelination in psychiatric disorders (e.g., bipolar disorder) and neurodegenerative conditions (e.g., multiple sclerosis) using relaxometry , magnetization transfer , and diffusion-weighted imaging . Recent methodological work includes 3D MERMAID sequences for motion-insensitive diffusion imaging and optimization of magnetization transfer saturation maps. Current projects integrate ultra-high field MRI with histological validation in preclinical models (e.g., marmoset brain sections), aiming to bridge microstructural metrics with macro-scale brain function. Applications span Alzheimer's disease risk assessment via white matter alterations, synaptic density mapping in psychosis, and cortical laminar differentiation studies.
Professor Roslyn Boyd serves as Scientific Director of the Queensland Cerebral Palsy and Rehabilitation Research Centre (QCPRRC) at the University of Queensland's School of Medicine. She leads a substantial multidisciplinary team of 38 researchers and provides clinical research leadership to 60 clinicians across the Queensland Paediatric Rehabilitation Service based at the Queensland Children's Hospital. As an NHMRC Leadership Fellow, Professor Boyd has established herself as an internationally recognized expert in cerebral palsy research and rehabilitation. Professor Boyd completed her primary training as a physiotherapist in Australia and London before earning her PhD in neuroscience at La Trobe University, the Brain Research Institute, and the Murdoch Children's Research Institute in Melbourne, for which she received the Premier's Commendation from the Victorian Government. She joined the University of Queensland in 2007 as a Smart State Fellowship recipient and has since led major research initiatives including an EBrain program grant funded by the Queensland Government Department of Innovation. Her research program focuses on three critical areas: the early natural history of motor and brain development in preschool children with cerebral palsy, novel rehabilitation approaches for children with hemiplegia, and early detection and intervention for infants at high risk of cerebral palsy. These research streams, all funded by the National Health and Medical Research Council of Australia, employ advanced brain imaging techniques including functional imaging, Diffusion Imaging, and Functional Connectivity to assess neuroplasticity changes resulting from therapeutic interventions. Her work bridges neuroscience, rehabilitation science, and clinical practice to develop evidence-based approaches that improve outcomes for children with neurodevelopmental conditions. Professor Boyd's extensive publication record of over 340 peer-reviewed manuscripts demonstrates a consistent focus on improving assessment methods, intervention efficacy, and early detection strategies for cerebral palsy. Her research spans from basic neuroscience investigations to large-scale clinical trials and implementation studies, creating a comprehensive evidence base that informs clinical practice worldwide. The publications reveal a growing emphasis on early intervention, neuroimaging biomarkers, and family-centered approaches to rehabilitation. Professor Boyd has received significant recognition for her contributions to the field, most notably the prestigious Gayle Arnold Award from the American Academy of Cerebral Palsy and Developmental Medicine, which she has received three times. This repeated honor underscores her international standing and the impact of her research on clinical practice. As an NHMRC Leadership Fellow, she represents the highest tier of Australian health and medical researchers. Through her leadership of major research programs and collaborations, Professor Boyd has secured over $40 million in research funding, enabling large-scale projects that directly impact clinical practice. Her work with multidisciplinary teams has produced evidence that informs clinical guidelines and treatment approaches used by healthcare professionals globally. She actively mentors junior researchers and clinicians, fostering the next generation of experts in pediatric rehabilitation. The Queensland Cerebral Palsy Rehabilitation and Research Centre, under Professor Boyd's direction, serves as a vital hub for translational research, connecting scientific discovery with clinical application. The center's work with the Centre for Extracellular Vesicle Nanomedicine demonstrates interdisciplinary reach beyond traditional cerebral palsy research, exploring innovative approaches to understanding and treating neurodevelopmental conditions.
